The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Vimta Labs Ltd

Vimta Labs Ltd

BSE 524394 · NSE VIMTALABS · ISIN INE579C01029 · Group B · Active

Healthcare › Healthcare › Healthcare Services › Healthcare Research, Analytics & Technology

₹616.55

-1.78%

BSE close, 28 August 2026

Market cap

₹2,755.17 cr

4.5 cr shares · Micro cap

Free float

₹946.36 cr

as published

P/E · P/B

34.6× · 8.15×

EPS ₹17.83 · BV ₹75.65

FY25-26 rev / PAT

407.29 / 77.51

₹ cr, as filed

Filings, window

16

6 selected · 38%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹377.30 52-WK HIGH ₹902.85 ₹616.55 46% of range
Against 52-week high-31.7%
Against 52-week low+63.4%
Day change-1.78%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹17.83
Price / earnings34.58×
Price / book8.15×
Book value — derived, price ÷ P/B₹75.65
Return on equity23.57%
Operating margin37.70%
Net margin19.29%

Consistency check

P/B ÷ P/E, which must equal ROE
23.57%
ROE as published
23.57%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 109.07 21.04 4.71 37.70% 19.29%
Mar-26 · Q 109.25 21.11 4.73 38.55% 19.33%
FY25-26 407.29 77.51 17.40 36.56% 19.03%

Quarter on quarter

Revenue, quarter on quarter
-0.2%
Net profit, quarter on quarter
-0.3%
Operating margin, quarter on quarter
-85 bps

Disclosure profile 16 filings in the window

0 median 17.0 p75 · 25 sector max 52 16 47th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Concall Transcript1
Credit Rating1
Investor Presentation1
Press Release1
Results1
Selected sub-total6
Procedural
Analyst / Investor Meet4
General2
Clarification1
ESOP Allotment1
Newspaper Publication1
Trading Window1
Procedural sub-total10
Total16

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

16 filings · 6 selected · busiest 2026-07-20

Filing rhythm · the twelve most recent

2026-07-202026-09-30

SelectedProcedural

Filings

16 in the window · 7 earlier on record

  1. 30 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation for closure of Trading Window.

    Insider Trading / SAST / Closure of Trading Window View filing →

  2. 16 September 2026 ·

    ESOP Allotment

    Allotment of ESOP / ESPS

    Allotment of Employee Stock Options under "Vimta Labs Employee Stock Option Plan 2021".

    Company Update / Allotment of ESOP / ESPS View filing →

  3. 8 September 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst/ Institutional Investor Meet.

    Company Update / Analyst / Investor Meet View filing →

  4. 2 September 2026 ·

    Credit Rating

    Credit Rating

    Disclosure on Credit Rating.

    Company Update / Credit Rating View filing →

  5. 1 September 2026 ·

    General

    Clarification Regarding Inc rease In Volume Of Our Securities Across Exchanges.

    Reply to the clarification regarding increase in volume.

    Company Update / General View filing →

  6. 1 September 2026 ·

    Clarification

    Clarification sought from Vimta Labs Ltd

    The Exchange has sought clarification from Vimta Labs Ltd on September 01, 2026, with reference to Movement in Volume. The reply is awaited.

    Company Update / Clarification

  7. 21 August 2026 ·

    General

    Intimation On Cyber Security Inc ident

    Intimation on cyber security incident

    Company Update / General View filing →

  8. 28 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst Meeting.

    Company Update / Analyst / Investor Meet View filing →

  9. 28 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst Meeting.

    Company Update / Analyst / Investor Meet View filing →

  10. 24 July 2026 ·

    Concall Transcript

    Earnings Call Transcript

    Transcript - Q1 Earnings Conference Call- FY 2026-27

    Company Update / Earnings Call Transcript View filing →

  11. 21 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication - Q1 FY 2026-27

    Company Update / Newspaper Publication View filing →

  12. 20 July 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Outcome

    Q1 - FY 2026-27 - Audio Recording of the Earnings Call.

    Company Update / Analyst / Investor Meet View filing →

  13. 20 July 2026 ·

    Press Release

    Press Release / Media Release

    Press Release - Unaudited Financial Results - 30.06.2026.

    Company Update / Press Release / Media Release View filing →

  14. 20 July 2026 ·

    Investor Presentation

    Investor Presentation

    Investor Presentation - Q1 FY 2026-27

    Company Update / Investor Presentation View filing →

  15. 20 July 2026 ·

    Results

    Q1 FY- 2026-27 - Unaudited Financial Results.

    Unaudited Financial Results for the 1st Quarter ended 30.06.2026.

    Result / Financial Results View filing →

  16. 20 July 2026 ·

    Board Outcome

    Board Meeting Outcome for Q1 FY- 2026-27 - Unaudited Financial Results.

    Unaudited Financial Results for the 1st Quarter ended 30.06.2026.

    Board Meeting / Outcome of Board Meeting View filing →

RSS feed for Vimta Labs Ltd · the 50 most recent filings